• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AVX THROMBECTOMY SET; CATHETER, EMBOLECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AVX THROMBECTOMY SET; CATHETER, EMBOLECTOMY Back to Search Results
Model Number 45026
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Low Blood Pressure/ Hypotension (1914)
Event Date 04/20/2023
Event Type  Death  
Event Description
It was reported that a patient died.In 2022, the patient was referred for percutaneous coronary intervention twice for chronic kidney diseases.Two to three days ago, before the procedure, the patient was receiving dialysis treatment.The target lesion was located in the left brachiocephalic vein.An angioget avx catheter was selected for arteriovenous fistula thrombectomy and uses 10ml of tissue plasminogen activator (tpa) with ns 250ml for medication.The device was run for 300 seconds of thrombectomy; operator stopped using the device due to poor condition of the patient and blood pressure was low.After the procedure was completed, and few minutes later of recovery, the patient was moved to er and eventually died due to cardiac arrest.
 
Event Description
It was reported that the patient died due to cardiac arrest.In 2022, the patient was referred for percutaneous coronary intervention two times, for chronic kidney disease.Two to three days before the procedure, the patient received dialysis treatment.The target lesion was located in the left brachiocephalic vein.An angioget avx catheter was selected for an arteriovenous fistula thrombectomy and 10ml of tissue plasminogen activator (tpa) with 250ml of normal saline, was used in the procedure.Thrombectomy was performed for 300 seconds, when use of the device was stopped, due to poor condition of the patient and low blood pressure.After the procedure was completed, the patient was moved to the emergency room and later died due to cardiac arrest.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AVX THROMBECTOMY SET
Type of Device
CATHETER, EMBOLECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key16950050
MDR Text Key315424342
Report Number2124215-2023-23884
Device Sequence Number1
Product Code DXE
Combination Product (y/n)N
Reporter Country CodeKS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number45026
Device Catalogue Number45026
Device Lot Number0030934867
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/20/2023
Initial Date FDA Received05/17/2023
Supplement Dates Manufacturer Received05/18/2023
Supplement Dates FDA Received05/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/13/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age65 YR
Patient SexMale
-
-